POC Urinalysis Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

POC Urinalysis Market: Test Type (Sediment, Biochemical,  Flow-Cytometric, Microscopic),  By Application ( UTI, Diabetes,  Liver Disease, Kidney, Pregnancy), End-User (Hospitals, Diagnostic Labs, Others) By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

POC Urinalysis Market size is valued at USD 3.44 billion in 2021 and is expected to reach USD 4.95 billion by 2028, at a CAGR of 6.9% during the forecast period 2022-2028. Latest technologies and increased demand for point-of-care (POC) urine diagnostic tests are projected to drive the urinalysis research market. In the laboratory, there is a strong demand for technically improved urinalysis tools that can offer reliable results in a fast manner. Integrated systems that can do the initial screening and required confirmation testing with microscopy are being used by several mid-and high-volume laboratories to automate their urine testing. Laboratories have had a constant demand for adaptable urinalysis solutions to meet the rising needs of their network. On the other hand, rising applications from advanced markets, as well as the adoption of integrated urinalysis systems, would create several possibilities, resulting in the rise of the point of care (POC) urinalysis market over the projection period. The accessibility of low-quality devices, as well as erroneous findings during crises, are expected to stifle the development of the point-of-care (POC) urinalysis market over the forecast period. The high costs associated with the use of automated analyzers will be the most significant impediment to the market’s expansion. Urinalysis is an important aspect of any normal health examination. In addition to disease-specific cardiac biomarkers, chemical substances, and cells/casts, this diagnostic approach may identify disease-specific biomarkers, chemical compounds, and cells/casts in urine samples. Urinalysis is also commonly used for early disease detection and pregnancy and fertility testing. The urinalysis market is predicted to expand due to factors such as rising worldwide incidence of kidney illnesses and urinary tract infections, rising health problems connected with the elderly population, and the development of increasingly improved equipment. POC presents a number of issues, the most significant of which is quality assurance. The conclusion of the test is frequently contrasted with traditional pathology to ensure the accuracy of the test result. Several fast diagnostic tests, especially those used in emergency situations, have failed to deliver correct results. The lack of clarity about the outcome is preventing the widespread use of point-of-care diagnostic equipment. For a complete list of the variables that will drive and challenge the growth of the POC Urinalysis market over the forecast period.

POC Urinalysis Market

MARKET SUMMARY
-
6.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.9%
  • Largest Market– North-America
  • Fastest Growing Market– Asia-Pacific

POC Urinalysis Market

  • The POC Urinalysis market is exceedingly divided and depends on new item dispatches and clinical consequences of items.
  • Henceforth the real players have utilized different procedures, for example, new item dispatches, clinical preliminaries, showcase activities, high cost on innovative work, understandings, joint endeavors, organizations, acquisitions, and others to build their impressions in this market.
  • Market members are always occupied with the presentation of novel demonstrative items trying to guarantee their supportability and increment the entrance of their item portfolio.
Key Players
  • ARKRAY,
  • ACON Laboratories,
  • Bio-Rad Laboratories,
  • Dahaner,
  • Hoffmann-La Roche Ltd.
POC Urinalysis Market

Drivers And Restraints

Factors such as growing demand for point-of-care testing, enhancement in the global geriatric population, new advancement in technology innovation of urinalysis propels the market growth of POC Urinalysis. Moreover, growth in healthcare expenditure, development of basic medical insurance systems in the near future boost the growth of the POC Urinalysis market. However, factors like lack of laboratory staff, High cost associated with advanced urine analyzers, acceptance of fully automated urine analyzers in growing economies is lower, and stringent regulatory framework may hamper the growth of the POC Urinalysis market. The POC is utilized to distinguish urinary tract diseases (UTI) and different issues of the urinary tract. In patients with intense or constant conditions, for example, kidney ailment, the urinalysis might be requested at interims as a quick technique to help screen organ capacity, status, and reaction to treatment.


North-America got significant share

POC Urinalysis Market

Geographically POC Urinalysis Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America overwhelmed the general POC Urinalysis market. The presentation of cutting-edge POC Urinalysis by entering market players in the U.S., positive government activities guaranteeing the advancement of human services testing, and the high measure of medicinal services spending in this locale are the key components crediting to the biggest piece of the pie of this region. Asia Pacific is relied upon to develop at the most noteworthy CAGR amid the forecast period. Development in this fragment is driven by the components, for example, rising interest for POC Urinalysis products, expanding medicinal services use, rising pervasiveness of diabetes, and developing geriatric populace are driving the development of the POC Urinalysis market in this locale.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
POC Urinalysis Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Hoffmann-La Roche Ltd (Switzerland)
  • Dahaner (U.S.)
  • Bio-Rad Laboratories, Inc.  (U.S.)
  • ARKRAY, Inc. (Japan)
  • Siemens AG (U.S.)
  • ACON Laboratories Inc. (U.S.)
  • Sysmex Corporation (Japan)

Description

POC Urinalysis Market size is valued at USD 3.44 billion in 2021 and is expected to reach USD 4.95 billion by 2028, at a CAGR of 6.9% during the forecast period 2022-2028. Latest technologies and increased demand for point-of-care (POC) urine diagnostic tests are projected to drive the urinalysis research market. In the laboratory, there is a strong demand for technically improved urinalysis tools that can offer reliable results in a fast manner. Integrated systems that can do the initial screening and required confirmation testing with microscopy are being used by several mid-and high-volume laboratories to automate their urine testing. Laboratories have had a constant demand for adaptable urinalysis solutions to meet the rising needs of their network. On the other hand, rising applications from advanced markets, as well as the adoption of integrated urinalysis systems, would create several possibilities, resulting in the rise of the point of care (POC) urinalysis market over the projection period. The accessibility of low-quality devices, as well as erroneous findings during crises, are expected to stifle the development of the point-of-care (POC) urinalysis market over the forecast period. The high costs associated with the use of automated analyzers will be the most significant impediment to the market’s expansion. Urinalysis is an important aspect of any normal health examination. In addition to disease-specific cardiac biomarkers, chemical substances, and cells/casts, this diagnostic approach may identify disease-specific biomarkers, chemical compounds, and cells/casts in urine samples. Urinalysis is also commonly used for early disease detection and pregnancy and fertility testing. The urinalysis market is predicted to expand due to factors such as rising worldwide incidence of kidney illnesses and urinary tract infections, rising health problems connected with the elderly population, and the development of increasingly improved equipment. POC presents a number of issues, the most significant of which is quality assurance. The conclusion of the test is frequently contrasted with traditional pathology to ensure the accuracy of the test result. Several fast diagnostic tests, especially those used in emergency situations, have failed to deliver correct results. The lack of clarity about the outcome is preventing the widespread use of point-of-care diagnostic equipment. For a complete list of the variables that will drive and challenge the growth of the POC Urinalysis market over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX